BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  NeuroVive Pharmaceutical AB and To-BBB technologies BV to Jointly Develop Therapy for Stroke

  October 25, 2010

   · 

  3 min read
• Drug Development

  Intercell AG Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections

  October 25, 2010

   · 

  4 min read
• Business

  Ore Pharmaceuticals Inc. Gets $5.3 Million Investment From Steel Partners

  October 25, 2010

   · 

  3 min read
• Business

  Valeant Pharmaceuticals International to Announce 2010 Third Quarter Results on November 4, 2010

  October 25, 2010

   · 

  1 min read
• Drug Development

  TRACON Pharmaceuticals, Inc. Announces Upcoming Scientific Presentations on Clinical-Stage Cancer Therapeutics TRC105 and TRC102

  October 25, 2010

   · 

  1 min read
• BioForest

  Omeros Corporation Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State’s Life Sciences Discovery Fund to Advance its GPCR Program

  October 25, 2010

   · 

  8 min read
• Business

  Alere Inc. Schedules Conference Call for 10:00 a.m. ET November 1, 2010 to Discuss Third Quarter 2010 Results

  October 25, 2010

   · 

  1 min read
• Deals

  Aegerion Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering

  October 25, 2010

   · 

  1 min read
• Drug Development

  Antigenics Inc. (Lexington, MA) Announces Expansion of Phase 2 Trial in Glioma

  October 25, 2010

   · 

  1 min read
• Immune Network Ltd.'s Immunitor Therapy is a Potential Breakthrough Against Tuberculosis

  October 25, 2010

   · 

  1 min read